CHLORAMPHENICOL PALMITATE

SynDRA canonical compound SYN0008315 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Mechanism of action	protein synthesis inhibitor
Indication	meningitis, fever, cholera
Disease area	infectious disease, endocrinology

Mechanisms of action (all sources)

chloromycetin palmitate
chloramphenicol.palmitate
Detreopal
CAP-palmitate
Chloromycetin palmitate
Chloramphenicol monopalmitate
Chlorambon
Clorolifarina
(2R,3R)-2-(2,2-Dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl palmitate
CHEBI:3605
43VU4207NW
NSC 756675
NCGC00159489-04
[(2R,3R)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] hexadecanoate
(2R,3R)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl hexadecanoate
Rel-(2R,3R)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl palmitate
Hexadecanoic acid, 2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl ester, (R-(R*,R*))-
CAP-P
UNII-43VU4207NW
Chloramphenicol palmitate [JAN]
Chloramphenicol palmitate (ester)
EINECS 208-477-9
MFCD00083597
BRN 2826438
Chloramphenicol palmitate [USP:BAN:JAN]
Chloramphenicoli palmitas
AI3-51715
CHEMBL1506
Chloromycetin palmitate (TN)
4-13-00-02753 (Beilstein Handbook Reference)
SCHEMBL193727
DTXSID9048699
HY-B1599
ZINC8214521
Tox21_113094
CHLORAMPHENICOL PALMITATE [MI]
AKOS025401796